Human umbilical mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis

American Journal of the Medical Sciences

Volumn 346, Issue 6, 2013, Pages 486-493

  Ma, Hualin ^a   Wu, Yaojiong ^b   Xu, Ying ^c   Sun, Liping ^a   Zhang, Xinzhou ^a  

^a JINAN UNIVERSITY   (China)

^b TSINGHUA UNIVERSITY   (China)

^c Chancheng District Central Hospital of Foshan City   (China)

Author keywords

Adriamycin nephropathy; Focal segmental glomerulosclerosis (FSGS); Human umbilical cord mesenchymal stem cells (HuMSCs); Inflammatory

Indexed keywords

BROXURIDINE; CONNECTIVE TISSUE GROWTH FACTOR; DOXORUBICIN; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FOCAL GLOMERULOSCLEROSIS; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN UMBILICAL MESENCHYMAL STEM CELL; INFLAMMATION; KIDNEY DISEASE; KIDNEY FIBROSIS; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; RAT; UMBILICAL CORD; XENOGRAFT;

EID: 84890856975     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3182831777     Document Type: Article

References (34)

1. Villanueva S, Ewertz E, Carrión F, et al. Mesenchymal stem cell injection ameliorates chronic renal failure in a rat model. Clin Sci 2011;121:489-99
2. Spencer ND, Gimble JM, Lopez MJ. Mesenchymal stromal cells: Past, present, and future. Vet Surg 2011;40:129-39
3. Yi T, Song SU. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications. Arch Pharm Res 2012;35: 213-21
4. Golemovic M, Skific M, Cepulic BG. [Mesenchymal stem cells: Immunomodulatory properties and clinical application]. Lijec Vjesn 2012;134:42-9
5. De Miguel MP, Fuentes-Julian S, Blazquez-Martinez A, et al. Immunosuppressive properties of mesenchymal stem cells: Advances and applications. Curr Mol Med 2012;12:574-91
6. Yan-Wu G, Yi-Quan K, Ming L, et al. Human umbilical cord-derived Schwann-like cell transplantation combined with neurotrophin-3 administration in dyskinesia of rats with spinal cord injury. Neurochem Res 2011;36:783-92
7. Lee VW, Harris DC. Adriamycin nephropathy: A model of focal segmental glomerulosclerosis. Nephrology 2011;16:30-8
8. Choi SJ, Kim JK, Hwang SD. Mesenchymal stem cell therapy for chronic renal failure. Expert Opin Biol Ther 2010;10:1217-26
9. Yan-Wu G, Yi-Quan K, Ming L, et al. Human umbilical cord-derived Schwann-like cell transplantation combined with neurotrophin-3 administration in dyskinesia of rats with spinal cord injury. Neurochem Res 2011;36:783-92
10. Gratzner HG. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 1982; 218:474-5
11. Zhou H, Tian HM, Long Y, et al. Mesenchymal stem cells transplantation mildly ameliorates experimental diabetic nephropathy in rats. Chin Med J (Engl) 2009;122:2573-9
12. Rodriguez-Iturbe B, Quiroz Y, Shahkarami A, et al. Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat. Kidney Int 2005;68:1041-7
13. Rangan GK, Coombes JD. Renoprotective effects of sirolimus in nonimmune initiated focal segmental glomerulosclerosis. Nephrol Dial Transplant 2007;22:2175-82
14. Choi S, Park M, Kim J, et al. The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev 2009;18:521-9
15. Cavaglieri RC, Martini D, Sogayar MC, et al. Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model. Transpl Proc 2009;41: 947-51
16. Lee SR, Lee SH, Moon JY, et al. Repeated administration of bone marrow-derived mesenchymal stem cells improved the protective effects on a remnant kidney model. Ren Fail 2010;32:840-8
17. Asanuma H, Vanderbrink BA, Campbell MT, et al. Arterially delivered mesenchymal stem cells prevent obstruction-induced renal fibrosis. J Surg Res 2011;168:e51-9
18. Kelley R, Werdin ES, Bruce AT, et al. Tubular cell-enriched subpopulation of primary renal cells improves survival and augments kidney function in rodent model of chronic kidney disease. Am J Physiol Renal Physiol 2010;299:F1026-39
19. Song JH, Humes HD. Renal cell therapy and beyond. Semin Dial 2009;22:603-9
20. Locatelli F, Giorgiani G, Di-Cesare-Merlone A, et al. The changing role of stem cell transplantation in childhood. Bone Marrow Transplant 2008; 41(suppl 2):S3-7
21. Chang JW, Hung SP, Wu HH, et al. Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis. Cell Transpl 2011;20:245-57
22. Magnasco A, Corselli M, Bertelli R, et al. Mesenchymal stem cells protective effect in adriamycin model of nephropathy. Cell Transpl 2008;17:1157-67
23. White C, Akbari A, Hussain N, et al. Estimating glomerular filtration rate in kidney transplantation: A comparison between serum creatinine and cystatin C-based methods. J Am Soc Nephrol 2005;16: 3763-70
24. Kampoli AM, Tousoulis D, Papageorgiou N, et al. Clinical utility of biomarkers in premature atherosclerosis. Curr Med Chem 2012;19: 2521-33
25. Rodríguez-Iturbe B, García García G. The role of tubulointerstitial inflammation in the progression of chronic renal failure. Nephron Clin Pract 2010;116:c81-c8
26. Abboud HE. Growth factors in glomerulonephritis. Kidney Int 1993; 43:252-67
27. Daniel V, Trautmann Y, Konrad M, et al. T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clin Nephrol 1997;47:289-97
28. Polhill T, Zhang GY, Hu M, et al. IL-2/IL-2Ab complexes induce regulatory T cell expansion and protect against proteinuric CKD. J Am Soc Nephrol. 2012;23:1303-8
29. Zhu C, Huang S, Ding G, et al. Protective effects of Huang Qi Huai granules on adriamycin nephrosis in rats. Pediatr Nephrol 2011;26: 905-13
30. Wang LM, Chi YJ,Wang LN, et al. [Expression of interleukin-6 in rat model of doxorubicin-induced nephropathy]. Zhongguo Dang Dai Er Ke Za Zhi 2010;12:912-4
31. Lin Q, Zheng J, Ai S, et al. [Mechanism of combined treatment with Shenkangling Decoction and prednisone in rats with adriamycininduced nephropathy]. Zhong Xi Yi Jie He Xue Bao 2009;7:661-6
32. Wang Y, Wang DH. Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-beta/Smad signaling in DOCA-salt hypertension. Mol Med 2011;17:1204-12
33. Tsai PY, Ka SM, Chao TK, et al. Antroquinonol reduces oxidative stress by enhancing the Nrf2 signaling pathway and inhibits inflammation and sclerosis in focal segmental glomerulosclerosis mice. Free Radic Biol Med 2011;50:1503-16
34. Ito Y, Aten J, Bende RJ, et al. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 1998;53:853-61